Refine
Has Fulltext
- yes (13)
Is part of the Bibliography
- yes (13)
Document Type
- Journal article (13)
Language
- English (13)
Keywords
- neuroendocrine tumor (6)
- PRRT (5)
- CXCR4 (4)
- PET (4)
- Positronen-Emissions-Tomografie (4)
- theranostics (4)
- PET/CT (3)
- RADS (3)
- peptide receptor radionuclide therapy (3)
- NET (2)
- SSTR (2)
- endoluminal (2)
- negative pressure (2)
- vacuum-assisted closure (2)
- 177Lu (1)
- 68Ga-DOTATATE/-TOC (1)
- <sup>18</sup>F-FDG (1)
- <sup>68</sup>Ga-Pentixafor (1)
- BON-1 (1)
- C-X-C motif chemokine receptor 4 (1)
- DOTATOC (1)
- GCA (1)
- GI (1)
- Gastrointestinal (1)
- MAG3 (1)
- MS-18 (1)
- NEC (1)
- Neuroendocrine (1)
- Neuroendocrine Tumor (1)
- Oncology (1)
- PMR (1)
- QGP-1 (1)
- Radionuclide Therapy (1)
- SSTR-RADS (1)
- Standardisierung (1)
- Wnt (1)
- [177Lu]/[90Y]PentixaTher (1)
- [18F]FDG PET/CT (1)
- [68Ga]PentixaFor (1)
- [\(^{68}\)Ga] Pentixafor (1)
- [\(^{68}\)Ga]Ga-FAPI (1)
- [\(^{68}\)Ga]Pentixafor (1)
- anastomotic leak (1)
- anastomotic leakage (1)
- chemokine receptor (1)
- endoradiotherapy (1)
- endoscopic (1)
- esophageal perforation (1)
- fibroblast activation protein (1)
- gastrointestinal perforation (1)
- giant cell arteritis (1)
- inflammation (1)
- personalized medicine (1)
- polymyalgia rheumatica (1)
- positron emission tomography (1)
- prostate cancer (1)
- prostate-specific membrane antigen (PSMA) (1)
- radioligand therapy (1)
- renal scintigraphy (1)
- reporting and data system (1)
- reporting and data systems (1)
- somatostatin receptor (1)
- somatostatin receptor (SSTR) (1)
- standardization (1)
- vasculature (1)
- vasculitis (1)
- β-catenin (1)
Institute
- Klinik und Poliklinik für Nuklearmedizin (11)
- Medizinische Klinik und Poliklinik II (11)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (2)
- Medizinische Klinik und Poliklinik I (2)
- Pathologisches Institut (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 701983 (4)
(1) Background: We aimed to quantitatively investigate [\(^{68}\)Ga]Ga-FAPI-04 uptake in normal organs and to assess a relationship with the extent of FAPI-avid tumor burden. (2) Methods: In this single-center retrospective analysis, thirty-four patients with solid cancers underwent a total of 40 [\(^{68}\)Ga]Ga-FAPI-04 PET/CT scans. Mean standardized uptake values (SUV\(_{mean}\)) for normal organs were established by placing volumes of interest (VOIs) in the heart, liver, spleen, pancreas, kidneys, and bone marrow. Total tumor burden was determined by manual segmentation of tumor lesions with increased uptake. For tumor burden, quantitative assessment included maximum SUV (SUV\(_{max}\)), tumor volume (TV), and fractional tumor activity (FTA = TV × SUV\(_{mean}\)). Associations between uptake in normal organs and tumor burden were investigated by applying Spearman's rank correlation coefficient. (3) Results: Median SUV\(_{mean}\) values were 2.15 in the pancreas (range, 1.05–9.91), 1.42 in the right (range, 0.57–3.06) and 1.41 in the left kidney (range, 0.73–2.97), 1.2 in the heart (range, 0.46–2.59), 0.86 in the spleen (range, 0.55–1.58), 0.65 in the liver (range, 0.31–2.11), and 0.57 in the bone marrow (range, 0.26–0.94). We observed a trend towards significance for uptake in the myocardium and tumor-derived SUV\(_{max}\) (ρ = 0.29, p = 0.07) and TV (ρ = −0.30, p = 0.06). No significant correlation was achieved for any of the other organs: SUV\(_{max}\) (ρ ≤ 0.1, p ≥ 0.42), TV (ρ ≤ 0.11, p ≥ 0.43), and FTA (ρ ≤ 0.14, p ≥ 0.38). In a sub-analysis exclusively investigating patients with high tumor burden, significant correlations of myocardial uptake with tumor SUV\(_{max}\) (ρ = 0.44; p = 0.03) and tumor-derived FTA with liver uptake (ρ = 0.47; p = 0.02) were recorded. (4) Conclusions: In this proof-of-concept study, quantification of [\(^{68}\)Ga]Ga-FAPI-04 PET showed no significant correlation between normal organs and tumor burden, except for a trend in the myocardium. Those preliminary findings may trigger future studies to determine possible implications for treatment with radioactive FAP-targeted drugs, as higher tumor load or uptake may not lead to decreased doses in the majority of normal organs.